IRIS
SARACINO, ANNALISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.375
AS - Asia 7.267
EU - Europa 4.812
SA - Sud America 1.907
AF - Africa 414
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 10
AN - Antartide 1
Totale 28.799
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.070
SG - Singapore 3.060
BR - Brasile 1.465
CN - Cina 1.361
HK - Hong Kong 1.075
IT - Italia 977
DE - Germania 797
VN - Vietnam 636
SE - Svezia 618
RU - Federazione Russa 599
FR - Francia 463
FI - Finlandia 377
GB - Regno Unito 307
IN - India 224
UA - Ucraina 183
AR - Argentina 152
CA - Canada 141
CI - Costa d'Avorio 135
BD - Bangladesh 134
ID - Indonesia 131
MX - Messico 104
IQ - Iraq 97
ZA - Sudafrica 91
NL - Olanda 84
PK - Pakistan 78
EC - Ecuador 75
PL - Polonia 75
TR - Turchia 70
JP - Giappone 61
VE - Venezuela 57
CO - Colombia 55
AT - Austria 54
BE - Belgio 51
SA - Arabia Saudita 50
ES - Italia 49
PH - Filippine 43
MA - Marocco 38
IE - Irlanda 34
CL - Cile 31
TN - Tunisia 30
KE - Kenya 29
JO - Giordania 26
LT - Lituania 26
UZ - Uzbekistan 26
CZ - Repubblica Ceca 23
MY - Malesia 23
PY - Paraguay 22
PE - Perù 19
JM - Giamaica 16
IL - Israele 15
KZ - Kazakistan 15
AE - Emirati Arabi Uniti 14
AZ - Azerbaigian 14
DZ - Algeria 14
ET - Etiopia 14
PS - Palestinian Territory 14
CH - Svizzera 12
TW - Taiwan 12
CR - Costa Rica 11
EG - Egitto 11
HR - Croazia 11
LY - Libia 11
NP - Nepal 11
RS - Serbia 11
UY - Uruguay 11
BO - Bolivia 10
GR - Grecia 10
AU - Australia 9
KW - Kuwait 8
LB - Libano 8
PA - Panama 8
OM - Oman 7
AL - Albania 6
BG - Bulgaria 6
BH - Bahrain 6
BY - Bielorussia 6
HU - Ungheria 6
IR - Iran 6
NG - Nigeria 6
QA - Qatar 6
RO - Romania 6
SR - Suriname 6
KR - Corea 5
NI - Nicaragua 5
PT - Portogallo 5
TH - Thailandia 5
TT - Trinidad e Tobago 5
UG - Uganda 5
DO - Repubblica Dominicana 4
EU - Europa 4
GH - Ghana 4
HN - Honduras 4
KG - Kirghizistan 4
LA - Repubblica Popolare Democratica del Laos 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
SY - Repubblica araba siriana 4
XK - ???statistics.table.value.countryCode.XK??? 4
AO - Angola 3
GE - Georgia 3
Totale 28.739
Salva come PNG Salva come JPEG
Città #
Ashburn 1.747
Singapore 1.724
Fairfield 1.560
Hong Kong 1.069
Woodbridge 1.037
San Jose 870
Houston 775
Chandler 709
Seattle 667
Cambridge 534
Wilmington 514
Ann Arbor 476
Nyköping 472
Dallas 463
Beijing 456
Jacksonville 384
New York 313
Munich 285
Lauterbourg 283
Los Angeles 242
Helsinki 219
Council Bluffs 183
Lawrence 180
Roxbury 179
Ho Chi Minh City 173
Nanjing 173
Abidjan 135
São Paulo 132
Hanoi 130
Falkenstein 125
Bari 116
Des Moines 107
Buffalo 105
Jakarta 88
Princeton 88
Santa Clara 87
Boardman 81
London 77
Frankfurt am Main 72
Brooklyn 71
Dong Ket 68
San Diego 66
Inglewood 65
Chicago 62
Rome 62
Warsaw 59
Montreal 56
Tokyo 55
Milan 51
Moscow 47
Mexico City 46
Brussels 44
Rio de Janeiro 44
Stockholm 44
Atlanta 42
Johannesburg 42
Turku 42
Hebei 40
Orem 40
Nuremberg 38
Denver 36
Shenyang 36
Toronto 36
Dublin 34
Curitiba 33
Chennai 32
Nanchang 31
Paris 31
Jiaxing 30
Belo Horizonte 29
San Francisco 28
Baghdad 26
Mumbai 26
Tianjin 26
Brasília 25
Lahore 25
Quito 25
Da Nang 24
Dearborn 24
Salt Lake City 24
Pune 23
Amsterdam 22
Columbus 22
Guayaquil 22
Haiphong 22
Nairobi 22
Phoenix 22
Tashkent 22
The Dalles 22
Poplar 21
Vienna 21
Amman 20
Ankara 20
Düsseldorf 20
Guangzhou 20
Hải Dương 20
Boston 19
Caracas 19
New Delhi 19
Falls Church 18
Totale 19.111
Salva come PNG Salva come JPEG
Nome #
Anemia as a risk factor for disease progression in patients admitted for COVID-19: data from a large, multicenter cohort study 400
Influence of HLA-B18 on liver fibrosis progression in a cohort of HIV/HCV coinfected individuals 369
Discontinuation of initial antiretroviral therapy in clinical practice: Moving toward individualized therapy 365
Economic evaluation of HIV treatments: The I.CO.N.A. cohort study 235
First Case of Paraphimosis as a Severe Complication of Monkeypox 229
Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated with Incident and Prevalent Type 2 Diabetes in Persons Living with HIV 221
Variability OF HIV-1 V2 env domain for integrin binding: Clinical correlates 194
Cerebrospinal fluid compartmentalization of HIV-1 and correlation with plasma viral load and blood–brain barrier damage 186
HCV mono-infected and HIV/HCV co-infected individuals treated with direct-acting antivirals: to what extent do they differ? 185
Antiretroviral genotypic resistance in plasma RNA and whole blood DNA in HIV-1 infected patients failing HAART 185
HIV-RNA decay in paired blood and semen samples of subjects receiving their first dolutegravir-based ART regimen 183
Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patients. 177
Access to HAART in HIV-Infected Immigrants: A Retrospective Multicenter Italian Study 174
A 75-year-old woman presenting with nasal vestibulitis 172
Potential diagnostic properties of chest ultrasound in thoracic tuberculosis—A systematic review 172
An outbreak of HIV-1 BC recombinants in Southern Italy 171
Biochemical and inflammatory modifications after switching to dual antiretroviral therapy in HIV-infected patients in Italy: A multicenter retrospective cohort study from 2007 to 2015 171
Low-level viraemia, measured as viraemia copy-years, as a prognostic factor for medium-long-term all-cause mortality: a MASTER cohort study 169
An intricate case of multidrug resistant Plasmodium falciparum isolate imported from Cambodia 167
Survival in HIV-Infected Patients after a Cancer Diagnosis in the cART Era: Results of an Italian Multicenter Study. 156
Importance of Baseline Prognostic Factors With Increasing Time Since Initiation of Highly Active Antiretroviral Therapy: Collaborative Analysis of Cohorts of HIV-1-Infected Patients 156
Reduced community viral load does not coincide with a reduction in the rate of new HIV diagnoses and recent infections: data from a region of southern Italy 155
A 75-year-old woman presenting with nasal vestibulitis 155
Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: Data from the ICONA cohort 154
Comment on: Integrase strand-transfer inhibitor polymorphic and accessory resistance substitutions in patients with acute/recent HIV infection 154
The elderly and direct antiviral agents: Constraint or challenge? 152
HIV-1 coreceptor tropism: A syllogistic connection with the veterans aging cohort study index and the CD4/CD8 ratio 151
Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy 151
Safety and effectiveness of a 12-week course of sofosbuvir and simeprevir ± ribavirin in HCV-infected patients with or without HIV infection: a multicentre observational study 150
Chronic Inflammation in a Long-Term Cohort of HIV-Infected Patients According to the Normalization of the CD4:CD8 Ratio 149
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004–2014 149
Response to first-line ritonavir-boosted protease inhibitors (PI/r)-based regimens in HIV positive patients presenting to care with low CD4 counts: Data from the Icona Foundation Cohort 149
Improved virological outcome in non-B patients: a possible role for baseline coreceptor tropism 147
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: An observational cohort study 147
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison 146
Co-receptor switch during HAART is independent of virological success 145
Cryoglobulinemia in subjects with HCV infection alone, HIV infection and HCV/HIV coinfection 139
Correlates of HIV-1 shedding in cervicovaginal secretions and effects of antiretroviral therapies 139
Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA <50 cp/mL 139
Cancer incidence and mortality for all causes in HIV-infected patients over a quarter century: a multicentre cohort study. 139
Prevalence of diabetes mellitus in newly diagnosed pulmonary tuberculosis in Beira, Mozambique 138
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline VIRO-immunological status and outcome in patients under first-line ART 138
Trend of estimated glomerular filtration rate during ombistasvir/paritaprevir/ritonavir plus dasabuvir± ribavirin in HIV/HCV co-infected patients 137
Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL 136
Incidence of tuberculosis among HIV-Infected patients receiving highly active antiretroviral therapy in Europe and North America 136
Renal function changes in HCV-infected patients with chronic kidney disease during and after treatment with direct antiviral agents 135
Hepatic encephalopathy in the course of anti-HCV therapy with paritaprevir/ritonavir, ombitasvir, dasabuvir and ribavirin 134
Short-Term Variations in Neutrophil-to-Lymphocyte and Urea-to-Creatinine Ratios Anticipate Intensive Care Unit Admission of COVID-19 Patients in the Emergency Department 134
Splenic abscesses as a first manifestation of Crohn's disease: A case report 133
Social determinants of therapy failure and multi drug resistance among people with tuberculosis: A review 132
A multidrug-resistant (MDR) HIV type 1 infection in a homosexual man and identified source patient 132
Cefiderocol-Based Combination Therapy for "Difficult-to-Treat" Gram-Negative Severe Infections: Real-Life Case Series and Future Perspectives 131
Seroconversion and indolent course of COVID-19 in patients with multiple sclerosis treated with fingolimod and teriflunomide 130
The at risk child clinic (ARCC): 3 years of health activities in support of the most vulnerable children in Beira, Mozambique 130
First Case of Candida Auris Sepsis in Southern Italy: Antifungal Susceptibility and Genomic Characterisation of a Difficult-to-Treat Emerging Yeast 129
Mortality in migrants living with HIV in western Europe (1997-2013): A collaborative cohort study 129
Are the proposed env mutations actually associated with resistance to maraviroc? 129
Effects of Therapy with Maraviroc on the Carotid Intima Media Thickness in HIV-1/HCV Co-infected Patients 129
Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus 129
CD4 and CD4/CD8 ratio progression in HIV-HCV infected patients after achievement of SVR 128
Evolution of antiretroviral prescription and response over a period of 8 years: An Italian multicentre observational prospective cohort study 128
Cohort Profile: Standardized Management of Antiretroviral Therapy Cohort (MASTER Cohort). 128
Epidemiological multicentric Italian society of infectious and tropical diseases study on prevalence of tropical diseases in hospitalized immigrants in Italy during 2002 127
Immunological and virological response to antiretroviral treatment in migrant and native men and women in Western Europe; is benefit equal for all? 127
Continued Decay of HIV Proviral DNA Upon Vaccination With HIV-1 Tat of Subjects on Long-Term ART: An 8-Year Follow-Up Study 127
HIV infection and protease genetic diversity in a rural area of the Southern Central African Republic 126
Premature lesions of the carotid vessels in HIV-1 infected patients treated with protease inhibitors 126
Pulmonary Artery Filling Defects in Covid-19 Patients Revealed Using CT Pulmonary Angiography: A Predictable Complication? 126
HIV-1 biological phenotype and predicted coreceptor usage based on V3 loop sequence in paired PBMC and plasma samples 125
Mutational patterns of paired blood and rectal biopsies in HIV-infected patients on HAART 125
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004–2014 124
Long-term durability of tenofovir-based antiretroviral therapy In relation to the Co-administration of other drug classes in routine clinical practice 123
Very high pre-therapy viral load is a predictor of virological rebound in HIV-1-infected patients starting a modern first-line regimen 123
V3 sequences and paired HIV isolates from 52 non-subtype B HIV type 1-infected patients 122
Hepatitis B and immigrants: a SIMIT multicenter cross-sectional study 121
Cefiderocol Versus Colistin for the Treatment of Carbapenem-Resistant Acinetobacter baumannii Complex Bloodstream Infections: A Retrospective, Propensity-Score Adjusted, Monocentric Cohort Study 120
Frequent cervicovaginal shedding of HIV-1 in asymptomatic, non-severely immunodeficient women 120
Tuberculosis and diabetes: Current state and future perspectives 120
Difficulties in classifying a/g recombinants: methodological problems or genetic variability? 119
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection? 119
Projections of non-communicable disease and health care costs among HIV-positive persons in Italy and the U.S.A.: A modelling study 119
Risk of chronic kidney disease among patients developing mild renal impairment during tenofovir-containing antiretroviral treatment 119
Focused ultrasound to diagnose HIV-associated tuberculosis (FASH) in the extremely resource-limited setting of South Sudan: a cross-sectional study 119
Gaining back what is lost: recovering the sense of smell in mild to moderate patients after COVID-19 119
Bamlanivimab and Etesevimab administered in an outpatient setting for SARS-CoV-2 infection 119
Dalbavancin Efficacy and Impact on Hospital Length-of-Stay and Treatment Costs in Different Gram-Positive Bacterial Infections 118
Clinical and epidemiological features of HIV/AIDS infection among migrants at first access to healthcare services as compared to Italian patients in Italy: a retrospective multicentre study, 2000-2010. 118
Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir Combination Treatment in Patients with HIV/HCV Co-Infection: Results of an Italian Compassionate Use Program 118
Genotypic analysis of the protease and reverse transcriptase of non-B HIV type 1 clinical isolates from naïve and treated subjects 117
Multidisciplinary Approach in the Treatment of Descending Necrotizing Mediastinitis: Twenty-Year Single-Center Experience 116
"In vitro" spontaneous production of B-chemokines by endocervical and endometrial short-term bioptic cultures 115
Direct-acting antivirals for HIV/HCV co-infected individuals: as good as it gets? 115
HCV and diabetes: Towards a 'sustained' glycaemic improvement after treatment with DAAs? 114
Predictors of therapy failure in newly diagnosed pulmonary tuberculosis cases in Beira, Mozambique. 114
Recurrent neurosurgical site infection by extensively drug-resistant P. aeruginosa treated with cefiderocol: a case report and literature review 114
Direct-Acting Antiviral-Induced Hepatitis C Virus Clearance and Herpesvirus Reactivation: A Double Face of Janus? 113
Reproductive choice in individuals HIV-1 infected in South Eastern Italy 113
Tocilizumab and corticosteroids for COVID-19 treatment in elderly patients 112
Drug Resistance Mutations and Newly Recognized Treatment-Related Substitutions in the HIV-1 Protease Gene: Prevalence and Associations With Drug Exposure and Real or Virtual Phenotypic Resistance to Protease Inhibitors in Two Clinical Cohorts of Antiretroviral Experienced Patients 112
Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: An observational cohort study 112
Totale 14.688
Salva come PNG Salva come JPEG
Categoria #
all - tutte 119.762
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 119.762
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021488 0 0 0 0 0 0 0 0 0 239 94 155
2021/20221.309 86 158 21 61 52 106 81 91 82 93 183 295
2022/20232.087 316 204 150 143 225 293 39 285 311 18 57 46
2023/20241.149 80 216 68 88 111 277 37 42 28 36 40 126
2024/20254.991 125 93 314 142 99 423 542 516 263 344 656 1.474
2025/202612.260 1.611 791 1.141 1.689 1.530 853 1.374 452 1.574 1.245 0 0
Totale 30.045